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ABSTRACT
ACROLEIN IS A CRITICAL MEDIATOR OF ALCOHOL-INDUCED LIVER AND
INTESTINAL INJURY IN ALCOHOLIC LIVER DISEASE
Wei-Yang (Jeremy) Chen
May 19, 2016
Alcohol consumption can cause alcoholic liver disease (ALD), which remains a
major cause of morbidity and mortality in the United States. Chronic alcohol
consumption causes a pro-oxidant environment in the liver and increases hepatic
lipid peroxidation. Acrolein is the most reactive and toxic aldehyde generated
through lipid peroxidation. Acrolein forms protein adducts and triggers
endoplasmic reticulum (ER) stress and hepatocyte apoptosis, which are
recognized etiologic factors in ALD. Several studies have established the critical
role of the gut-liver axis in ALD pathogenesis, wherein alcohol-induced gut barrier
dysfunction contributes to liver injury. This study investigates, in vitro and in vivo,
the pathogenic role of acrolein as a major mediator of intestinal barrier dysfunction,
and hepatic ER stress and injury in ALD.
Accumulation of acrolein adducts was seen in response to alcohol
consumption in mouse livers and intestines. Intestinal acrolein accumulation
correlated with serum lipopolysaccharides (LPS), suggesting that elevated
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acrolein is associated with gut permeability. Hepatic acrolein buildup correlated
with ER stress, steatosis, JNK activation, apoptosis and liver injury.
Further, hallmark ER chaperones GRP78 and GRP94 were minimally
induced, suggesting that ER-adaptive/protective responses were insufficient; the
underlying cause was lack of activation of relevant transcription factors. We used
cultured hepatic and intestinal cells to examine the direct in vitro effects of acrolein
in comparison to alcohol. The in vivo gut-liver effects of alcohol consumption were
mimicked by direct in vitro acrolein exposure in intestinal Caco-2 and hepatic
H4IIEC cells. Specifically, acrolein down-regulated tight junction proteins, altered
their localization, and disrupted barrier function. Similarly, in vitro acrolein
exposure in hepatic cells triggered ER stress and induced apoptosis. Notably,
these alcohol-induced effects were attenuated by hydralazine, a known acrolein
scavenger.
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CHAPTER 1
INTRODUCTION
Alcohol consumption can lead to alcoholic liver disease (ALD), which remains a
major cause of morbidity and mortality worldwide and in the United States. Despite
the profound economic and health impacts, there is no FDA (Food and Drug
Administration) approved therapy for any stage of ALD [1], emphasizing the need
for research into therapeutic interventions during the early initiating stages of the
disease. Further, only about 20% of heavy alcohol drinkers develop liver disease,
and diet and environment are considered potential determining factors. The
pathogenesis of ALD is multi-factorial, and although oxidative stress, lipid
peroxidation, and endoplasmic reticulum (ER) stress are known etiologic factors
[2], the molecular mediators of hepatic injury remain poorly defined.
Alcohol liver disease (ALD)
Alcohol consumption is known to cause alcoholic liver disease (ALD) which
includes a spectrum of liver disorders (Figure 1), ranging from fatty liver (steatosis)
to steatohepatitis, fibrosis, cirrhosis, end stage liver disease and potentially
hepatocellular carcinoma (HCC) [3]. Steatosis is commonly found in approximately
90 percent of individuals who consume more than 60 g per day of alcohol, or about
five drinks per day [4]. Steatosis is reversible if the individuals stop or dramatically
reduce the amount of alcohol consumption. Histology evidence has shown fat
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accumulation of both small (i.e., microvesicular) and large (i.e., macrovesicular)
droplets within liver cells [5]. Some individuals with steatosis progress to more
serious liver disease such as alcoholic hepatitis, which is steatosis accompanied
by inflammation, neutrophil infiltration, hepatocyte necrosis, and Mallory bodies.
Approximately 10 to 35 percent of alcoholic patients may progress from steatosis
to fibrosis and eventually cirrhosis followed by end stage liver disease and possibly
hepatocellular carcinoma (HCC). The study of mechanisms and mediators that
contribute to ALD is critical to understand the development and progression of ALD
and to promote therapeutic development.

Figure 1: Progression of alcoholic liver disease.
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Alcohol metabolism and oxidative stress
Ingested alcohol passes through the portal circulation from the intestine and is
metabolized primarily in the liver. The process of ethanol metabolism involves at
least three distinct enzymatic pathways. Most of the alcohol in the human body is
first oxidized in the liver to acetaldehyde which is toxic. This process is catalyzed
by the cytosolic alcohol dehydrogenase (ADH), an NAD+-requiring enzyme
expressed at high concentrations in hepatocytes. ADH oxidizes ethanol to
acetaldehyde, which enters the mitochondria where it is oxidized to acetate by one
of several aldehyde dehydrogenases (ALDH) [6]. The microsomal ethanol
oxidizing system (MEOS) is the second major pathway for alcohol metabolism and
involves the cytochrome P450 enzyme 2E1 (CYP2E1) and the conversion of
NADPH to NADP+. This pathway is known to be highly induced in chronic alcohol
drinkers. CYP2E1 also plays an important role in alcohol metabolism; alcohol can
be oxidized by CYP2E1 to acetaldehyde, with generation of hydrogen peroxide
which causes oxidative stress in the liver cells. Minor pathways for alcohol
metabolism involve fatty acid ethyl ester (FAEE) synthase, or catalase in
peroxisomes.
Studies have shown that consumption of ethanol disrupts antioxidants
function, which leads to elevated oxidative stress and increased interactions
between free radicals and cellular components including lipids, proteins, and DNA,
which alter cellular structures and functions. The production of reactive oxygen
species (ROS) can be compensated for the antioxidant systems of the human
body. However, when excessive ROS production exceeds the capacity of
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physiological adaption to eliminate ROS, it could lead to health problems. The
superoxide and hydrogen peroxide are the most dominant forms of ROS and they
can cause acetaldehyde accumulation due to an imbalance of redox state.
Aldehyde dehydrogenase (ADH) is responsible for the oxidation of ethanol by
increasing the reduced form of nicotinamide adenine dinucleotide (NADH) which
results in a decrease of the NAD+/NADH ratio and triggers the conversion of
cytosolic xanthine dehydrogenase to xanthine oxidase, which is the enzyme
responsible for the production of superoxide radicals. NADH is involved in the
conversion of ferritin-bound iron to ferrous (Fe) (II) ions, and these ferrous ions
play important roles in free radical reactions which lead to the generation of
hydrogen peroxide, hydroxyl radicals, and increased lipid peroxidation [7, 8].
Alcohol-induced lipid peroxidation (LPO) generates Acrolein
Alcohol metabolism in the liver generates free radicals which cause oxidative
degradation of cellular polyunsaturated fatty acids (PUFAs) by LPO. Linoleic acid
(LA) is the most common PUFA found in foods in the western diet [9]. The
consumption of LA has dramatically increased from 2% to over 7% in the last
century. Notably, studies by our group and others have shown that consumption
of alcohol along with a diet rich in PUFAs (particularly, LA) gives rise to worse
alcohol-induced liver injury, compared to alcohol plus saturated fat diet [10].
Moreover, LA is a precursor of arachidonic acid and can be converted to
proinflammatory eicosanoids, which are thought to be involved in several chronic
diseases, including cancer and cardiovascular disease [11]. Linoleic acid enriched
diet is known to elevate lipid peroxidation (LPO). Alcohol-induced LPO is well
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documented in animal models, as well as in patients with ALD. The products of
LPO, including malondialdehyde (MDA), 4-hydroxynonenal (HNE) and acrolein,
are detected in samples from animals and humans after consuming alcohol. These
reactive aldehydes are highly likely to play a critical role in the pathology of ALD.
Of particular interest is acrolein which is the most toxic and reactive byproduct of
lipid peroxidation [12]. (Figure 2).

Figure 2: Proposed formation of acrolein from arachidonic acid (PUFA)
[13].

5

Acrolein, the reactive aldehyde from lipid peroxidation
Acrolein is listed as a Harmful and Potentially Harmful Constituent (HPHCs) among
volatile carbonyls in tobacco products by Food and Drug Administration (FDA), and
inhaled acrolein is a predominant rout of exposure for non-cancer respiratory
effects from tobacco smoking. It is a highly reactive α,β-unsaturated aldehyde with
three carbons and a double bond structure (Figure 3) and is formed endogenously
during lipid peroxidation [14]. Acrolein is also a biotransformation metabolite
formed from certain amino acids, allyl compounds and the anticancer drug,
cyclophosphamide [15]. Acrolein has the potential to rapidly deplete cellular
glutathione, and it reduces cellular antioxidant capacity [14]. Therefore acrolein
may serve as an important oxidative stress biomarker for lipid peroxidation [16].
Acrolein is the most abundant, toxic, and reactive aldehyde among lipid
peroxidation derived aldehydes, and it is over 100 times [12] more reactive and
forty times greater in concentration than other aldehydes such as 4-HNE [17]. Due
to its highly electrophilic nature, acrolein can form adducts with cellular nucleophilic
groups in lipids, nucleic acids, and proteins; these acrolein adducts can cause
cytotoxicity via irreversible adduction by disrupting cell signaling and mitochondrial
function of the cells to produce oxidative stress. Numerous mechanisms of toxicity
have been linked to acrolein such as adduct formation, ER stress, oxidative stress,
inflammation and mitochondrial dysfunction; acrolein forms covalent adducts with
DNA, proteins, and phospholipids. Notably, acrolein is also an environmental
pollutant arising from the combustion of wood, paper, fossil fuels, and plastics. It
is a major component of cigarette smoke and up to 600µg of acrolein is generated
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per cigarette [18]. This is particularly relevant for ALD given the high prevalence of
individuals that use/abuse both alcohol and cigarettes. Additionally, acrolein is
produced by overheating fats and oils, and is now considered a significant dietary
pollutant occurring in charred meats and fried foods [14, 18]. Thus, both
exogenous and endogenous acrolein generation may contribute to the
development/progression of liver diseases and the overall level of acrolein may
determine the extent of toxic effects and injury.

Figure 3: Chemical structure of acrolein.

Acrolein adducts
Acrolein is a strong electrophile and readily targets critical amino acid residues to
form mainly Michael addition-type amino acid adducts with cysteines, histidines
and

lysines

of

proteins;

the

acrolein-lysine

adduct,

N«-(3-formyl-3,4-

dehydropiperidino)lysine (FDP-lysine), is readily detectable using specific
antibodies [18], and can compromise the function of enzymes, transcription
factors, and zinc finger proteins, often with grave consequences. Acrolein is
associated with several chronic diseases, and elevated concentrations of acrolein-
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protein adducts are detected in the plasma of patients with several diseases,
including Alzheimer's [19], diabetes [20], Parkinson's [21], atherosclerosis [22],
chronic obstructive lung disease [14], spinal cord injury, diabetes mellitus, and
multiple sclerosis [23]. Accumulation of acrolein-adducted proteins can trigger ER
stress and the unfolded protein response [24].
The pathogenic mechanisms of alcohol liver disease
Some mechanisms postulated to contribute to ALD include inflammation,
mitochondrial dysfunction, ER stress, hepatocyte apoptosis and intestinal barrier
dysfunction. All of these mechanisms are associated with each other and one
mechanism/pathway can lead to other(s).
Inflammation
Inflammation is an early indicator of more serious liver disease and several
inflammatory response pathways are linked to ALD such as NF-κB, JNK, ROS,
interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). The inflammatory
response is driven primarily by immune and inflammatory cells such as
macrophages, monocytes, dendritic cells, neutrophils, and liver-resident Kupffer
cells in response to stimuli including LPS, TNFα, etc. The activation of
inflammasomes (e.g., NLRP3) also plays an important role in the inflammatory
response and results in the production of IL-1β, IL-6, IL-18, and TNF-α. TNF-α is
a cytokine which is responsible for the programmed cell death and apoptosis of
hepatocytes in alcohol-induced liver injury. TNF-α also promotes a series of
inflammation responses in the hepatocytes and leads to the production of other
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inflammatory cytokines [25]. Persistent cytokine secretion causes chronic
inflammation which leads to hepatitis, fibrosis, and cirrhosis [26].
Mitochondrial dysfunction
Mitochondria are the energy factories of the cells and produce ATP which is
required to maintain normal metabolic and repair functions of the cells. Studies
have shown that alcohol significantly decreases the viability of hepatocytes due to
an inability to maintain a sufficient rate of ATP synthesis. The oxidation of alcohol
by ADH and CYP2E1 and acetaldehyde by ALDH leads to a significant increase
in the hepatic NADH/NAD+ ratio and an increase in the production of ROS. The
enzyme activities of NADH dehydrogenase, succinate dehydrogenase and ATP
synthase are depressed when exposed to reactive species, including superoxide,
hydrogen peroxide and peroxynitrite, leading to the inactivation of mitochondrial
proteins and further decreases in the function of mitochondria in the cells [27, 28].
Disruption of mitochondrial function can trigger signaling cascades involving the
release of pro-apoptotic proteins from mitochondria, and activation of initiator and
effector caspases, leading to apoptotic cell death.
Endoplasmic Reticulum (ER) stress and unfolded protein response (UPR)
The endoplasmic reticulum (ER) is a network of interconnected tubules within the
cytoplasm of eukaryotic cells [29]. The ER plays a crucial role in cell homeostasis
and survival, and is responsible for synthesis, folding, assembly, and trafficking of
proteins; lipid biosynthesis; and regulation of intracellular calcium and redox
homeostasis [30]. The molecular chaperones/folding proteins in the ER (e.g.,
Grp78/BiP, Grp94, protein disulfide isomerase (PDI), calnexin, and calreticulin)
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ensure that only properly folded proteins reach their destinations; inappropriately
folded proteins are retained in the ER lumen for refolding or endoplasmic
reticulum–associated degradation (ERAD) [30]. Certain stimuli (such as altered
redox status, oxidative stress, unbalanced calcium, hypoxia, or energy deprivation)
can disturb ER function and lead to the accumulation of unfolded proteins in the
ER, thereby triggering ER stress and the unfolded protein response (UPR). To
restore ER homeostasis, the UPR adaptive mechanism upregulates the folding
capacity of the ER through induction of chaperones and foldases, and
downregulates the biosynthetic load through inhibition of protein synthesis and
degradation of misfolded proteins [30].
ER stress/UPR signaling pathways involve three major ER resident
transmembrane sensor proteins, inositol requiring protein 1 (IRE1), ds-RNAactivated protein kinase (PKR) like ER kinase (PERK), and activating transcription
factor 6 (ATF6), which are activated from their inhibitory binding with chaperone
GRP78/BiP. The first sensor, IRE1, a type I transmembrane protein with both a
serine/threonine kinase domain and endoribonuclease (RNase) activities, is
activated by transautophosphorylation. IRE1 transcriptionally forms spliced XBP1
(sXBP1) which activates UPR target genes and ERAD pathway genes. IRE1 also
activates the stress-signaling kinase, JNK, and the transcription factor, NFκB, both
of which can lead to proinflammatory cytokine production. The second sensor,
PERK, a type I transmembrane protein with a cytosolic serine/threonine kinase
domain, phosphorylates the eukaryotic initiation factor 2α-subunit (eIF2α), leading
to inhibition of translation and reduction of the protein load during ER stress. Also,
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p-eIF2α triggers activating transcription factor 4 (ATF4), which regulates ER
chaperone genes, ERAD pathway genes, amino acid metabolism genes, and the
proapoptotic transcription factor C/EBP homologous protein (CHOP, GADD153).
The third sensor, ATF6, a type II ER transmembrane protein with a CREB/ATF
bZIP transcription factor domain at the amino terminus, is activated by cleavage in
the Golgi complex and can translocate to the nucleus to activate chaperone gene
expression [31, 32]. Additionally, ATF6 also leads to upregulation of CHOP, and
affects SREBP activity and consequently, lipogenesis.
ER stress induces apoptosis
In order to counter ER stress in the cells, the UPR adaptive signaling pathway is
triggered. However, excessive or prolonged ER stress can overwhelm the adaptive
pathways, and cause apoptotic and necrotic cell death. The apoptosis pathway is
triggered to protect the cells if the PERK, ATF6, and IRE1 adaptive pathways fail
to mitigate ER stress [33]. Several mechanisms are involved in ER stress-induced
apoptosis such as the transcription factor C/EBP homologous protein (CHOP),
JNK, Bcl-2 family proteins, calcium and redox homeostasis, and caspase
activation [12].
ER stress triggers the JNK pathway via phosphorylation of IRE-1 with the
adaptor protein TRAF2 (tumor necrosis factor receptor (TNFR)-associated factor2) which phosphorylates and activates JNK [34]. Phosphorylated JNK activates
proapoptotic Bim and inactivates antiapoptotic Bcl-2 proteins, and triggers release
of cytochrome C through the mitochondrial death pathway. Calcium homeostasis
is associated with apoptosis; excess calcium release from the ER results in
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calcium accumulation in the mitochondria and results in release of apoptosis
effectors from mitochondria into the cytosol. Bcl-2 has the ability to reduce the
overflow of free calcium stored in the ER and prevent cell apoptosis.
The transcription factor CHOP/GADD153 is the best-known proapoptotic
pathway associated with ER stress. CHOP is a bZIP-containing transcription factor
that is a common point of convergence for all three arms of the UPR, with binding
sites for ATF6, ATF4 and XBP1s present within its promoter. CHOP is primarily
considered a pro-apoptotic transcription factor that mediates ER stress induced
cell death through the regulation of Bcl-2 family members. Also, CHOP
transcriptionally induces GADD34 and dephosphorylates p-eIF2α to enable protein
synthesis, concomitantly generating ROS and leading to oxidative stress and
inflammation [12]. The activation of ER stress, and consequent inflammation and
apoptosis may be a significant contributor to many forms of liver injury, including
ALD.
ER stress has been reported to contribute to alcohol-induced liver injury and
the progression of alcoholic liver disease in both animal and cell models [35-38].
Upregulation of ER stress related genes such as Grp78, Grp94, and CHOP has
been observed in acute and chronic alcohol feeding animal models and in patient
biopsies [39, 40]. Some factors that are thought to contribute to alcohol-induced
ER stress include acetaldehyde, oxidative stress, disrupted calcium homeostasis,
impaired one carbon metabolism, and epigenetic modifications.
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Metabolism and removal of acrolein and scavengers
Acrolein can deplete intracellular glutathione (GSH), GSH-linked glutathione-Stransferases, and aldose reductase rapidly for its detoxification [41], and acrolein
can be toxic unless removed or metabolized [42]. The primary pathway of acrolein
metabolism is conjugation with glutathione catalyzed by glutathione S-transferaseP (GSTP) [43, 44]. Acrolein is also metabolized by aldehyde dehydrogenase
(ALDH2), which is primarily responsible for clearance of acetaldehyde in the
alcohol metabolism. A recent study has shown that GSH is a major acroleindetoxifying compound. In the brain infarction of aging there is an increase in
acrolein and a decrease in GSH [45] (Figure 4). Acrolein scavengers have been
used clinically for other conditions and have demonstrated protection against
aldehyde-induced injury in experimental disease models.

Hydralazine, a

vasodilator and hypertension drug, was chosen due to it is effectiveness in
preventing acrolein-mediated oxidative stress and cell death in PC12 cells, and
tissue injury in spinal cord injury models [46]. Notably, the cytoprotective effects of
hydralazine are shown to occur not merely by acrolein scavenging but also by
effective trapping of acrolein-protein adducts [47]. Another acrolein scavenger,
carnosine, is a dipeptide and inhibits acrolein from forming protein-protein crosslinking and forming protein carbonyl groups [48].
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Figure 4: Alcohol metabolism and acrolein detoxification.

Gut-liver axis in alcoholic liver disease
Alcohol quickly distributes into the portal circulation and across biological
membranes to organs throughout the body. Alcohol-induced injuries are observed
in many organs including brain, immune system, kidney, lung, heart, pancreas,
and particularly, the gastrointestinal tract and liver. Increasing evidence suggests
that interactions between the intestine and liver (gut-liver axis) play a critical role
in the development/progression of ALD [49]. Alcohol is known to disrupt intestinal
epithelial barrier function

and

increase intestinal permeability,

allowing

translocation of bacteria and bacterial products such as endotoxin, flagellin, etc.
Endotoxin (lipopolysachharide, LPS) is recognized by toll-like receptors (TLRs) on
14

liver Kupffer cells (and possibly hepatocytes), resulting in inflammation and release
of proinflammatory cytokines such as TNFα, IL-1β, IL-8 and IL-18. These
cytokines, in turn, can affect both the liver and the intestine, and promote further
injury. In the liver, alcohol is known to cause ER stress, inflammation and
hepatocyte apoptosis and injury. Thus, interactions of the intestine and liver
involving altered intestinal permeability and systemic bacterial translocation, as
well as hepatic ER stress, inflammation and injury are critical in the development
and progression of ALD (Figure 5).

Figure 5: Pathogenesis of the Gut-Liver axis in ALD.

Intestinal barrier dysfunction and intestinal permeability
Intestinal barrier dysfunction is linked to various intestinal disorders including
inflammatory bowel disease, celiac disease, and diarrheal infection [50]. Several
disorders such as multiple sclerosis, Alzheimer's, Parkinson's and autism are
15

linked to intestinal barrier dysfunction and involve the activation of the
inflammatory response due to altered intestinal permeability (or leaky intestine)
[51]. Importantly, altered intestinal permeability is considered as a major causal
factor in the pathology of ALD [52]. Intestinal barrier function is maintained by
several components: mucus layer, anti-microbial peptides, tight junctions, and
adherence junctions. The tight junctions are controlled by the tight junction
proteins, including ZO proteins, claudins, and occludins [53]. The pathogenesis
of several gastrointestinal diseases relies mostly on disruption of tight junction
proteins [54, 55]. The intestinal barrier is primarily maintained by a single layer
of epithelial cells formed between the lumen and mucosal tissues which play a
critical role in maintaining normal human biological function [56]. It is the key
barrier in the body to prevent invasion of toxins, antigens and microorganisms
and loss of water and electrolytes. Moreover, it facilitates digestion and
absorption of nutrients from the diet [53, 57]. The intestinal epithelium is
comprised of several different cell types organized into crypts and villi. The
cellular components of the intestinal barrier includes the vascular endothelium,
the epithelial cell lining, and the mucus layer [53]. The principal cell types consist
of paneth cells, goblet cells, enterocytes, and enteroendocrine cells [58]. Among
these cells, the paneth cells in the crypts of the small intestine produce digestive
secretions, immune molecules, cell products such as cytokines, inflammatory
mediators and antimicrobial peptides (small peptides which can function as
chemoattractants), dendritic cell activators, and direct antimicrobial effectors
[53, 59]. Intestinal permeability is closely associated with the intestinal
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commensal microbiota and the innate immune system. The alterations of
intestinal permeability include gut microbiota modifications, mucus layer
alterations, and epithelial damage, which allow translocation of luminal contents
to the inner layers of the intestinal wall [53] or the circulation.
Tight junction proteins
All intestinal epithelial cells are connected at lateral membranes through formation
of an impermeable seal to the paracellular space with three major types of
junctional complexes--tight junctions, adherens junctions, and desmosomes.
These junctional complexes maintain intestinal barrier function and cell polarity by
separating the apical from basolateral membranes. Among these major junctional
complexes, the tight junctions are controlled by the tight junction proteins (TJPs)
which include claudins, occludin, zonula occludens occludins (ZO), junctional
adhesion molecules (JAM), and tricellulin proteins (Figure 6). The adherens
junctions are located below tight junctions and are important in cell-cell signaling,
epithelial restitution. Desmosomes support epithelial stability [56]. TJPs are multiprotein complexes located at the most apical end of the lateral membrane and are
composed of both transmembrane and cytoplasmic plaque proteins that interact
with the cytoskeleton directly. Moreover, TJs are the critical element of mucosal
epithelial permeability because of their ability to selectively control the paracellular
permeability for small molecules, ion, and water [57]. Therefore, the expression of
TJPs determines the normal function of the intestinal barrier and alterations are
associated with changes of intestinal permeability.
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The intercellular adhesion and paracelluar permeability are maintained and
regulated by the interactions of these TJPs in the cell surface [60]. Among these
key TJPs, claudins, occludin, junctional adhesion molecules (JAM), and tricellulin
are the major transmembrane proteins for establishing the selective paracellular
barrier. Intracellular molecules such as zonula occludens (ZO) and cingulin are the
major cytoplasmic plaque proteins located at the peripheral membrane [61]. In the
intestinal barrier structure, occludin, claudins, and tricellulin proteins are linked to
the adjacent cells in the actin cytoskeleton through cytoplasmatic scaffolding
proteins like ZO proteins [56]. Claudins are the backbone for constructing the tight
junction structure [62]. Interestingly, in the different segments of the GI tract, each
claudin shows a unique and diverse tissue expression pattern [57]. The ZO
proteins include three members (ZO-1, ZO-2, and ZO-3) [63], and the JAM family
includes three classical members (JAM-1, -2, and -3) and four related molecules
(JAM-4, JAM-L, CAR, and ESAM) [64]. Alterations in the levels and/or the
subcellular localization of these TJPs can result in intestinal barrier dysfunction.
Thus, TJPs are critical components of intestinal barrier function.
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Figure 6: Tight junction proteins [65].
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HYPOTHESIS
We hypothesize that acrolein plays a pathogenic role in the gut-liver injury of ALD.
Specifically, our hypotheses are:
1) Acrolein generation/accumulation in the liver contributes to alcohol-induced liver
injury by causing ER stress and consequent apoptotic cell death of hepatocytes.
2) Acrolein generation/accumulation in the intestine causes intestinal epithelial
barrier dysfunction leading to increased gut permeability and systemic bacterial
translocation by disruption of tight junctions, induction of ER stress and epithelial
cell death/dysfunction.
3) Acrolein clearance/removal protects against alcohol-induced gut-liver injury in
ALD. Acrolein scavengers (hydralazine) will alleviate accumulation of acrolein on
alcohol-induced intestine and liver injury in ALD.
SPECIFIC AIMS
Aim 1: To determine the impact of acrolein in alcohol-induced liver ER stress,
apoptosis and injury in ALD.
Aim 2: To determine the therapeutic potential of acrolein scavengers in protection
against alcohol-induced liver injury in ALD.
Aim 3: To determine the role of acrolein in alcohol-induced intestinal dysfunction
in ALD.
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CHAPTER 2
MATERIALS AND METHODS
Animal studies
Male C57BL/6J mice (10 weeks of age) were obtained from Jackson laboratories
(Bar Harbor, ME). They were maintained at 24°C with a 12h:12h light/dark cycle
and had free access to normal chow diet and tap water for 5 days before the start
of the experiment. The mice were fed (ad libitum) a Lieber-DeCarli liquid diet (BioServ Inc., Frenchtown, NJ) containing 5% ethanol (w/v or 35% of calories) or
maltose dextrin as control for 10 days, followed by a single oral gavage of ethanol
(5g/kg body weight) on day 11. After 9 hours, the mice were anesthetized with
Avertin. Plasma and tissue samples were collected for assays. Part of the liver
from the left lobe was harvested and fixed in 10% neutral-buffered formalin, while
the remaining liver tissue was snap frozen in liquid N2 and stored at −80°C. All
mice were treated according to the protocols reviewed and approved by the
Institutional Animal Care and Use Committee of the University of Louisville.
Reagents
General chemicals, carnosine, hydralazine, acrolein, and β-actin antibody were
purchased from Sigma Aldrich (St. Louis, MO).

All other antibodies were

purchased from Cell Signaling (Beverly, MA). Cell culture supplies were obtained
from Invitrogen (Carlsbad, CA).
Cell culture
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H4IIEC, a rat hepatoma cell line was obtained from American Type Culture
Collection (Rockville, MD).

All treatments were performed on sub-confluent

monolayers of cells. Cells were plated at the following densities: (i) 20,000 cells
per well for 96-well plates; (ii) 0.25x106 cells per well for 24-well plates; (iii) 0.5x106
cells per well for 6-well plates; (iv) 2.5x106 cells per 100mm plates. Cells were
cultured in the DMEM media (10% horse serum, 5% fetal bovine serum) at 37 °C
in a 5% CO2 environment. Cells were counted using a hemocytometer.
Caco-2 cells are colon carcinoma cells, which undergo a process of
spontaneous differentiation in culture and fully differentiate into mature enterocytes
in 21 days [66]. Caco-2 cells were obtained from the ATCC and were cultured in
Eagle’s minimal essential medium supplemented with 100 U/mL penicillin, 100
μg/mL streptomycin, and 10% fetal bovine serum at 37 °C in a 5% CO2
environment.
Caco-2 monolayer barrier function analysis
Resistance (TEER)
Caco-2 cells were cultured in Transwell inserts (Costar, Corning) for 21 days to
polarize and differentiate into an epithelial cell-like monolayer. Caco-2 monolayers
were measured with an epithelial volt ohmmeter (World Precision Instruments,
Sarasota, FL). Electrical resistance was recorded with three consecutive
measurements after subtracting the resistance value of the filters alone.
FITC-Dextran Assay (FD4)
Caco-2 cells were cultured in transwell inserts (Costar, Corning) for 21 days to
polarize and differentiate into epithelial cell-like monolayer. Fluorescein
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isothiocyanate–dextran-4 (FD-4) was added to the apical top of the culture and
incubated for 30 min. The basal medium was collected for Caco-2 cell permeability
measurement using a microplate fluorescence reader with an excitation
wavelength of 485 nm and an emission wavelength of 530 nm.
Isolation of RNA and RT-PCR
The messenger RNA (mRNA) levels of ER stress genes were analyzed by real
time polymerase chain reaction (RT-PCR). Total RNA (300ng), isolated using
Trizol (Invitrogen, Carlsbad, CA), was used in reverse transcription reactions as
described by the manufacturer. The resulting complementary DNA was then
subjected to PCR using specific primer pairs (Table 1), with 18s and TATA-binding
protein as internal controls. SYBR Green I dye was used for Real Time PCR in an
ABI prism 7500 sequence detection system.
Small interfering RNA transfection
Prior to alcohol or acrolein treatment, siRNAs specific for rat GSTP or scrambled
RNA (Thermo Fisher Scientific) as a negative control were transfected into H4IIEC
cells with Lipofectamine® RNAiMAX Transfection Reagent (Thermo Fisher
Scientific) according to the manufacturer’s instructions. The final concentration of
each transfected RNA was 25 nM. Inhibition of GSTP was confirmed by examining
GSTP mRNA and protein. Cells were treated 72h after transfection with alcohol or
acrolein for 24h.
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Mouse
mATF3_F1
mATF3_R1
mATF4_F1
mATF4_R1
mDDIT3_GADD_CHOP_F1
mDDIT3_GADD_CHOP_R1
mGRP78_F1
mGRP78_R1
mGRP94_F1
mGRP94_R1
mCyp2e1_F
mCyp2e1_R
mGstp1_F1
mGstp1_R1
mAdh1_F
mAdh1_R
Rat
rATF3_F1
rATF3_R1
rATF4_F1
rATF4_R1
rDDIT3_GADD_CHOP_F1
rDDIT3_GADD_CHOP_R1
rGRP78_F1
rGRP78_R1
rGRP94_F1
rGRP94_R1
Human
hsTjp1_F (ZO-1)
hsTjp1_R (ZO-1)
hsCldn1_F
hsCldn1_R
hsOcln_F
hsOcln_R
Human/Rat/Mouse
18Sreg3F
18Sreg3R

GCGCTGGAGTCAGTTACCGTCA
TTCTTCAGGGGCCGCCTCAGAC
AAGCCATGGCGCTCTTCACGA
AGTCCCCCGCCAACACTTCG
CCGGAACCTGAGGAGAGAGTGTT
AGCTGCCATGACTGCACGTGG
ACCACCTATTCCTGCGTCGGTGT
AGGCCACATACGACGGCGTG
AAAGGACTTGCGACTCGCCGG
TCTGACGAACCCGAAGGTCAGC
AGGGGACATTCCTGTGTTCC
TTACCCTGTTTCCCCATTCC
CCCTCTGTCTACGCAGCACT
CTCACACCGCCCTCGAAC
TGTTGAGAGCGTTGGAGAAG
CGCTTCGGCTACAAAAGTTG
GGGCCACCTCAGACTTGGTGACT
CATCGGATGTCCTCTGCGCTGG
GACAAGGCGGGCTCCTCAGAA
AAAGGCATCCTCCTTGCCGGTGT
TGTTGAAGATGAGCGGGTGGCAG
TGGACCGGTTTCTCTCTCCTCAGGT
GGACCACCTATTCCTGCGTCGGT
TGGCCGCATCGCCAATCAGA
CGTCCTGCTGACCTTCGGGTTT
CCAGGTCCTCTTCTACCGTGCCA
AGCACAGCAATGGAGGAAAC
CCCCACTCTGAAAATGAGGA
GGCAGATCCAGTGCAAAGTC
GGTGGCCACAAAGATTGCTA
ATGCCCTCTGCAACCAATTT
CCACAATAATCATGAACCCCAGT
CTCAACACGGGAAACCTCAC
CGCTCCACCAACTAAGAACG

Table 1: Primers for quantitative Real Time-PCR.
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MTT assay
Cell

viability

was

assessed

by

the

3-(4,5-dimethythiazol-2-yl)-2,5-

diphenyltetrazolium bromide (MTT) assay. After treatments, cells were washed
twice with PBS; then cell culture medium was replaced with medium containing 1
mg/ml MTT. After 1h, cells were lysed with100ul lysis buffer containing 20% SDS
and 50% N,N-dimethyformamide (DMF), and incubated at 37°C overnight. The OD
values were read at 570 nm.
Western blot analysis
Cells were lysed in lysis buffer (50 mM Tris•HCl, pH 7.4, 150 mM NaCl, 2 mM
EDTA, 4 mM Na3VO4, 40 mM NaF, 1% Triton X-100, 1 mM PMSF, 1% protease
inhibitor cocktail) and centrifuged at 14,000 g for 10 min. The supernatants were
collected and 26μg of equivalent protein in total cell lysates was resolved by SDSpolyacrylamide gel electrophoresis and transferred onto a polyvinylidene difluoride
membrane (Bio-Rad, Hercules, CA). Membranes were blocked for 1 h in blocking
buffer (5% nonfat dry milk in 0.1%TBST (10 mM Tris-HCl, pH 8.0, 150 mM NaCl,
and 0.1% Tween 20)) and incubated overnight at 4°C with the primary antibodies
diluted in blocking buffer. After washing with 0.1%TBST, the membranes were
incubated with appropriate secondary antibodies for 1 h at room temperature.
Proteins were visualized using an enhanced chemiluminescence system (ECL, GE
Healthcare, Piscataway, NJ) and quantified by densitometry analysis using
UNSCANIT (Silk Scientific, Inc., Orem, UT). The density ratio of each band
compared to its corresponding β-actin band was determined. The density ratio was
normalized to the untreated value which was set to 1.
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Histology:
Liver or intestinal sections were fixed in 10% buffered formalin for 24 hours and
embedded in paraffin. Tissue sections were deparaffinized, stained with
hematoxylin–eosin (H&E), and examined by light microscopy (×200 final
magnification).
ALT & AST assay
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity
were measured as markers of liver injury using commercially available reagents
from Thermo Fisher Scientific Inc. (Middletown, VA).
Oil Red O staining
Frozen liver sections were washed in phosphate buffered saline twice for 5
minutes. Oil-Red-O and 85% propylene glycol were added with agitation for 15
minutes, followed by washing in tap water.
Detection of apoptosis
TUNEL staining for apoptosis was performed using ApopTag® Peroxidase In Situ
Apoptosis Detection Kit (EMD Millipore Corporation, Billerica, MA).
Detection of acrolein adducts
Acrolein adducts were detected using an antibody specific for FDP-Lysine acrolein
adducts obtained from Cell Sciences. (Canton, MA). Quantitation was done and
calculated by ImageJ and MetaMorph microscope. Ten pictures from each liver
were used for analysis.
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Immunofluorescence microscopy
Ileum sections were fixed in 10% buffered formalin for 24 hours and embedded in
paraffin. Tissue sections were deparaffinized and incubated with polyclonal rabbit
anti-claudin-1, occludin, or ZO-1 antibodies from Invitrogen (Carlsbad, CA)
overnight at 4°C, followed by incubation of fluorescein isothiocyanate-conjugated
antibody from Invitrogen (Carlsbad, CA) for 30 minutes at room temperature.
Images were examined using a Nikon A1R-A1confocal microscope equipped with
a digital image analysis system (Pixera, San Diego,CA)
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.01 for
Windows (GraphPad Software, Inc., La Jolla, CA). One-way analysis of variance
(ANOVA) followed by Bonferroni post test analysis (for greater than two groups)
was used to evaluate significant differences between the compared groups. A pvalue of <0.05 was considered statistically significant. Data were expressed as
mean ± SEM.
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CHAPTER 3
RESULTS SECTION I: LIVER STUDIES.
In this study, we examined the contributory role of the lipid-derived aldehyde,
acrolein, to alcohol-induced liver injury using cultured rodent hepatoma cells
(H4IIEC), and the chronic+binge murine model of ALD, also called the NIAAA
(National Institute on Alcohol Abuse and Alcoholism) model. This is a wellaccepted mouse model for hepatic steatosis and hepatocellular injury in ALD, and
reflects a common drinking pattern in humans, particularly in patients with ALD
who are often chronic and binge drinkers [67, 68].
Alcohol consumption in mice leads to hepatic acrolein generation and
accumulation of acrolein adducts
In order to investigate the theory that acrolein is a pathogenic mediator of ALD, we
first examined whether alcohol consumption led to acrolein buildup in the liver.
Although free acrolein is extremely labile and difficult to quantify, it readily reacts
with cellular proteins to form covalent adducts which can then be assessed. A
marked increase was observed in the levels of acrolein-protein adducts (brown
staining of acrolein-FDP-lysine adducts) in the livers of alcohol-fed mice (Figure
7A) compared to controls, showing that alcohol consumption led to the hepatic
generation/accumulation of acrolein. The alcohol-induced acrolein adduct
accumulation was largely not zone-specific, but was slightly increased close to the
portal vein in some animals. Also, both cytoplasmic and nuclear accumulation was
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seen, suggesting that proteins in many subcellular locations were adducted by
acrolein. Quantification of acrolein adducts revealed a 3-fold, statistically
significant difference between control and alcohol-fed livers (Figure 7A).
To determine the mechanisms underlying alcohol-induced acrolein
accumulation, we examined enzymes that primarily metabolize alcohol, namely,
ADH and CYP2E1. Alcohol is known to upregulate CYP2E1 and increase its own
metabolism, thereby leading to oxidative stress and enhanced LPO. Hence, it is
likely to generate higher levels of the LPO-derived aldehydes, such as acrolein.
Accordingly, we examined CYP2E1 and ADH expression in the livers of control
versus alcohol-fed mice. As anticipated, alcohol feeding led to a robust increase in
CYP2E1 protein levels in the alcohol-fed mice (Figure 7B). However, CYP2E1
mRNA was decreased by alcohol feeding (Figure 7C). Similar effects were seen
in hepatic ADH, wherein ADH mRNA was decreased (Figure 7C) and ADH protein
levels were slightly increased by alcohol (Figure 7B). Alcohol-induced increase in
CYP2E1 protein in the absence of transcriptional upregulation of the mRNA, has
been proposed to be due to stabilization of the protein [69]; whether the same
occurs with ADH remains to be investigated. The concentration of acrolein in the
liver is modulated not only by its generation but also by the rate of detoxification or
removal. Since acrolein is primarily metabolized and cleared via conjugation with
glutathione catalyzed by the enzyme glutathione-s-transferase-Pi (GSTP) [18], we
also examined the effects of alcohol on hepatic GSTP levels. Alcohol consumption
resulted in a decrease in the hepatic levels of both GSTP mRNA (Figure 7C) and
GSTP protein (Figure 7B) as seen in alcohol-fed mice compared to control,
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suggesting that the decrease in GSTP may contribute to acrolein accumulation in
the livers of alcohol-fed mice.
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Figure 7A. Alcohol consumption leads to accumulation of acrolein-protein
adducts in mice livers.
Top: Accumulation of acrolein adducts in mice livers by immunohistochemistry
using specific FDP-lysine antibodies (20x and 80x magnification).
Bottom: Quantification of acrolein adducts in (A). Mean ± SEM, n=6 mice,
***p<0.001 compared to control by student’s t-test. C=Control; E=Alcohol.
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Figure 7B. Alcohol consumption leads to upregulation of ADH and CYP2E1,
and downregulation of GSTP in mice livers.
Western blot analysis of ADH, CYP2E1 and GSTP was performed using total cell
lysates. Blots were reprobed with antibody to β-actin to ensure equivalent
loading. Densitometry analysis was performed using Imagelab software. Density
ratio was calculated using β-actin as control. Numbers represent the mean of
density ratio for each group of mice pair-fed the control or ethanol diet.
C=Control; E=Alcohol.
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Figure 7C. Alcohol consumption leads to downregulation of ADH, CYP2E1,
and GSTP in mice livers.
Total RNA was evaluated for mRNA expression by real-time PCR using primers
specific for ADH, CYP2E1 and GSTP genes. Data are presented as the mean ±
SEM (n=6). Statistical analysis was performed using GraphPad Prism Software
using one-way ANOVA followed by Bonferroni posttest. **p<0.01, ***p<0.001.
C=Control; E=Alcohol.
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Using cultured rodent hepatic cells that are known to metabolize alcohol
(H4IIEC cells), we assessed whether in vitro exposure to alcohol resulted in the
accumulation of acrolein adducts, similar to that seen in livers of alcohol-fed mice.
Considerable acrolein adduct accumulation was seen in H4IIEC cells that were
treated for 24h with alcohol (200mM) compared to untreated cells (Figure 8A).
Alcohol is metabolized in the liver by ADH or CYP2E1 into its primary metabolite,
acetaldehyde, which causes increased ROS production leading to enhanced LPO.
Based on the acrolein buildup seen in alcohol-exposed mice and cultured cells, we
explored the direct role of the alcohol metabolite, acetaldehyde, in acrolein
generation and adduct accumulation in hepatocytes. Cells were exposed in vitro
to acetaldehyde (50µM or 100µM) for 24h, and acrolein adduct levels were
examined. Similar to alcohol, direct exposure of cells to acetaldehyde resulted in
significant acrolein adduct accumulation (Figure 8A). Quantification showed that
treatment with alcohol and 100µM acetaldehyde caused a statistically significant
increase in acrolein adducts, and a similar trend (but not statistically significant)
was seen with the lower concentration of acetaldehyde (Figure 8A). Once formed,
acetaldehyde is further metabolized by aldehyde dehydrogenase (ALDH) enzymes,
particularly ALDH2, which is also known to metabolize and remove reactive
unsaturated aldehydes such as acrolein. Hence, we tested whether ALDA1, a
known agonist of ALDH2, affected alcohol-induced acrolein buildup. Pretreatment
of cells with ALDA1 prior to alcohol exposure considerably decreased the
accumulation of acrolein adducts (Figure 8B), showing that stimulating ALDH2
attenuated alcohol-induced acrolein accumulation. Further, to determine whether
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acrolein buildup was dependent on alcohol metabolism, H4IIEC cells were also
exposed to various known inhibitors of alcohol metabolism, prior to alcohol
exposure. Treatment of cells with either pyrazole or 4-methylpyrazole (which
suppress both ADH and CYP2E1 dependent alcohol metabolism [70])
substantially attenuated the accumulation of alcohol-induced acrolein adducts
(Figure 8B). In comparison, allyl sulfide, which is a more selective CYP2E1
inhibitor, was less effective in blocking alcohol-induced acrolein buildup,
suggesting that both ADH and CYP2E1 pathways led to acrolein generation, and
that inhibition of only one metabolic pathway was insufficient to eliminate total
acrolein adduct accumulation (Figure 8B). Thus, alcohol consumption and
metabolism causes acrolein accumulation by simultaneously upregulating
enzymes that lead to acrolein generation and downregulating the enzyme that
metabolizes and removes acrolein. In order to further investigate the role of
downregulation of GSTP in the alcohol-induced buildup of acrolein adducts, we
used siRNA in H4IIEC cells to effectively inhibit GSTP mRNA and protein (Figure
8C). Genetic inhibition of GSTP by siRNA led to an increase in the accumulation
of acrolein adducts (Figure 8D) following treatment with alcohol or acrolein, which
was not seen in cells transfected with scrambled RNA control. These data
confirmed that the downregulation of GSTP by alcohol may be a novel mechanism
that contributes to enhanced alcohol-induced hepatic acrolein generation and
adduct accumulation. Thus, our data show that alcohol consumption and
metabolism causes acrolein accumulation by simultaneously upregulating
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enzymes that lead to acrolein generation and downregulating the enzyme that
metabolizes and removes acrolein.
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Figure 8A. Effect of acetaldehyde on alcohol-induced acrolein adduct
accumulation in cultured hepatic cells.
Top: Accumulation of acrolein adducts by immunocytochemistry using specific
FDP-lysine antibodies (20x magnification) in H4IIEC cells treated for 24h as
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follows: Untreated control cells (C) or cells treated with 200mM alcohol (E), 50µM
acetaldehyde (AA50) or 100µM acetaldehyde (AA100).
Bottom: Quantification of acrolein adducts in (A). Mean ± SEM, n=4, **p<0.01
and ***p<0.001 compared to control by ANOVA - Bonferroni analysis.
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Figure 8B. Effect of pharmacologic modulators of alcohol metabolism on
alcohol-induced acrolein adduct accumulation in cultured hepatic cells.
Top: Accumulation of acrolein adducts (20x magnification) in H4IIEC cells treated
for 24h as follows: Untreated control cells (C); cells treated with 200mM alcohol
alone (E); or 200mM alcohol in the presence of 10 µM Alda1 (ALDA1+E); 10 µM
4-methyl pyrazole (4MP+E); 10 µM Pyrazole (PYR+E); or 10 µM allyl sulfide
(AS+E).
Bottom: Quantification of acrolein adducts in (C). Mean ± SEM, n=4, **p<0.01
and ***p<0.001 compared to control by ANOVA - Bonferroni analysis.
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Figure 8C. Effect of inhibition of GSTP on alcohol-induced acrolein adduct
accumulation in cultured hepatic cells.
Inhibition of GSTP mRNA and protein by siRNA transfection in H4IIEC cells. For
PCR analysis *p<0.05 compared to control. For Western blot, the numbers
represent mean densitometry ratios normalized to β-actin. C=Control; si=GSTP
siRNA; and sc=scrambled RNA as negative control.
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Figure 8D. Effect of inhibition of GSTP on alcohol-induced acrolein adduct
accumulation in cultured hepatic cells.
Accumulation of acrolein adducts (20x magnification) in transfected H4IIEC cells,
and quantification of acrolein adducts. *p<0.05 and ***p<0.001 compared to
control by ANOVA - Bonferroni analysis. C=Control; E=200mM Alcohol; A=20µM
Acrolein; si=GSTP siRNA; and sc=scrambled RNA as negative control.
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Alcohol-induced hepatic acrolein adduct accumulation is associated with
ER stress, with minimal activation of ER adaptive/protective responses
The alcohol-induced accumulation of acrolein-adducted proteins in the liver is likely
to increase the burden on the cellular ER protein folding machinery, which if
overwhelmed, can trigger ER stress. Indeed, in our study, alcohol feeding and the
resultant acrolein adduct accumulation was associated with upregulation of the
prototypical ER stress markers, activating transcription factors ATF3 and ATF4, at
the mRNA (Figure 9A) and protein levels (Figure 9B). The increase in ATF3 and
ATF4 was attributed to phospho-activation of the upstream signaling proteins,
PERK and eukaryotic translation initiation factor 2A, (eIF2α) (Figure 9C).
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Figure 9A. Alcohol-induced accumulation of acrolein adducts causes
hepatic ER stress in mice livers.
Total RNA was evaluated for mRNA expression by real-time PCR using primers
specific for ATF3 and ATF4 genes. Data are presented as the mean ± SEM
(n=6). Statistical analysis was performed using Student’s t-test. **p<0.01.
C=Control; E=Alcohol.
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Figure 9B. Alcohol-induced accumulation of acrolein adducts causes
hepatic ER stress in mice livers.
Western blot analysis of ATF3 and ATF4 was performed using total cell lysates.
Blots were reprobed with antibody to β-actin to ensure equivalent loading.
Densitometry analysis was performed using Imagelab software. Density ratio was
calculated using β-actin as control. Numbers represent the mean of density ratio
for each group of mice pair-fed control or ethanol diet. C=Control; E=Alcohol.
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Figure 9C. Phospho-PERK and phospho-eIF2α protein levels. Western blot
analysis of Phospho-PERK and phospho-eIF2α was performed using total cell
lysates. Blots were reprobed with antibody to β-actin to ensure equivalent
loading. Densitometry analysis was performed using Imagelab software. Density
ratio was calculated using β-actin, total PERK or eIF2α as control. Numbers
represent the mean density ratio for each group of mice pair-fed control or
ethanol diet. C=Control; E=Alcohol.
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Further, the effect of alcohol on the adaptive/protective responses
associated with ER stress was also studied by examining the gene expression of
hallmark ER chaperones, GRP78 and GRP94; these chaperones can promote
protein folding, and thereby relieve ER stress and provide protection. A small (but
statistically significant) increase was seen in the mRNA levels of both GRP78 and
GRP94 (Figure 10A); while at the protein level, only GRP78 was marginally
elevated (Figure 10B) in alcohol fed mice, suggesting that cellular ER-adaptive
responses were not robustly activated. Next, to determine the underlying cause,
we examined the transcription factors that are thought to regulate chaperone gene
expression, namely, ATF6 and X-box binding protein-1 (XBP1). Activation of ATF6
by proteolytic cleavage from the inactive ~90kDa fragment into the active ~50kDa
cleaved form (Figure 10C) was seen in alcohol-fed mice, showing that the ATF6mediated ER stress pathway was also triggered in this model of alcohol
consumption in mice. XBP1 is activated by unconventional splicing of XBP1 mRNA
due to ER stress-induced activation of IRE1 endonuclease activity via
oligomerization, and subsequent autophosphorylation. Accordingly, we examined
IRE1 phosphorylation and XBP1 splicing in alcohol-fed mice and observed that
alcohol consumption slightly decreased IRE1 phosphorylation (Figure 10C). Also,
we observed a lack of spliced XBP1 (Figure 10D), and consequently, no induction
of XBP1s protein in the majority of livers of alcohol-fed mice (Figure 10E).
Interestingly, the unspliced XBP1u (~26kDa) was slightly increased in alcohol fed
mice at the mRNA and protein level; the relevance of this finding remains to be
clarified. These data show that alcohol feeding induced ER stress and activated
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ATF6, but failed to splice XBP1, and these actions did not upregulate ER
chaperones.
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Figure 10A. Alcohol-induced accumulation of acrolein adducts induces ER
chaperone mRNA expression in mice livers.
Total RNA was evaluated for chaperone gene expression by real-time PCR using
primers specific for GRP78 and GRP94 genes. Data are presented as the mean
± SEM (n=6). Statistical analysis was performed using Student’s t-test. *p<0.05
and **p<0.01. C=Control; E=Alcohol.
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Figure 10B. Alcohol-induced accumulation of acrolein adducts induces
minimal ER chaperone proteins in mice livers.
Western blot analysis of GRP78 and GRP94 was performed using total cell
lysates. Blots were reprobed with antibody to β-actin to ensure equivalent
loading. Densitometry analysis was performed using Imagelab software. Density
ratio was calculated using β-actin as control. Numbers represent the mean
density ratio for each group of mice pair-fed control or ethanol diet. C=Control;
E=Alcohol.
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Figure 10C. Alcohol-induced accumulation of acrolein adducts activates
ATF6 cleavage and decreases IRE phosphorylation in mice livers.
Western blot analysis of ATF6 and cleaved/active ATF6, and phospho-IRE1 and
total IRE1 was performed using total cell lysates. Blots were reprobed with
antibody to β-actin to ensure equivalent loading. Densitometry analysis was
performed using Imagelab software. Density ratio was calculated using β-actin or
total IRE1 as control. Numbers represent the mean density ratio for each group
of mice pair-fed control or ethanol diet. C=Control; E=Alcohol.

51

Figure 10D. Alcohol-induced accumulation of acrolein adducts does not
induce XBP1 splicing in mice livers.
XBP1 splicing by semi-quantitative endpoint reverse transcription-PCR visualized
by agarose gel electrophoresis.
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Figure 10E. Alcohol-induced accumulation of acrolein adducts does not
induce spliced XBP1 protein in mice livers.
Western blot analysis of XBP1s and XBP1u was performed using total cell
lysates. Blots were reprobed with antibody to β-actin to ensure equivalent
loading. Densitometry analysis was performed using Imagelab software. Density
ratio was calculated using β-actin as control. Numbers represent the mean
density ratio for each group of mice pair-fed control or ethanol diet. C=Control;
E=Alcohol.
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Acrolein adduct accumulation and ER stress occur concurrently with
proapoptotic signaling
Uncontrolled ER stress in cells can result in apoptosis, which is thought to occur
by various proapoptotic pathways [71]. Accordingly, we examined the effects of
alcohol consumption on relevant ER-associated apoptotic signaling in alcohol fed
mice. The activation of IRE1 leads to its interaction with TRAF2 and ASK1, and
subsequent activation of the mitogen/stress kinase, JNK, which is associated with
ER stress-induced apoptosis. The sustained activation of JNK by phosphorylation
is implicated in hepatocyte apoptosis and several forms of liver injury [72].
Hepatocytes express both isozymes JNK1 (46kDa) and JNK2 (54kDa) which
regulate inflammation, cell proliferation and death in a cell-type dependent and
contextual manner. Our data show that alcohol consumption caused significant
phospho-activation of both JNK1 and JNK2, while total JNK was very slightly
reduced compared to control mice (Figure 11A).
Another relevant ER-driven apoptotic pathway involves the proteolytic
activation of the ER-resident caspase-12, which is known to subsequently activate
caspase-9 and caspase-3, resulting in apoptotic cell death [73]. Alcohol
consumption also caused proteolytic activation of caspase-12, as demonstrated
by a decrease in pro-caspase-12 (~55kDa) and a concurrent increase in the
cleaved form (~38kDa) (Figure 11B). The third, and possibly the most well
characterized, pathway of ER stress-induced apoptosis is via upregulation of
CHOP, which is primarily responsible for ER stress-induced cell death [74, 75].
Activated CHOP leads to alterations in Bcl2 and BAX leading to activation of the

54

mitochondrial death pathway that is known to be involved in alcohol-induced liver
injury. The CHOP gene promoter contains binding sites for transcription factors
ATF4 and ATF6 which are both activated by alcohol (Figures 9 and 10,
respectively). Correspondingly, alcohol consumption resulted in a ~5-fold
upregulation of CHOP mRNA (Figure 11C) and a concomitant increase in CHOP
protein (Figure 11D). Thus, alcohol consumption and consequent acrolein build up
in mice activates ER-associated proapoptotic signaling pathways.
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Figure 11A. Alcohol-induced hepatic acrolein build-up and consequent ER
stress leads to proapoptotic signaling in mice livers.
Western blot analysis of Phospho-JNK and total JNK was performed using total
cell lysates. Blots were reprobed with antibody to β-actin to ensure equivalent
loading. Densitometry analysis was performed using Imagelab software. Density
ratio was calculated using total JNK or β-actin as control. Numbers represent the
mean density ratio for each group of mice pair-fed control or ethanol diet.
C=Control; E=Alcohol.

56

Figure 11B. Alcohol-induced hepatic acrolein build-up and consequent ER
stress leads to proapoptotic signaling in mice livers.
Western blot analysis of Pro- and cleaved/active caspase 12 protein levels was
performed using total cell lysates. Blots were reprobed with antibody to β-actin to
ensure equivalent loading. Densitometry analysis was performed using Imagelab
software. Density ratio was calculated using β-actin as control. Numbers
represent the mean density ratio for each group of mice pair-fed control or
ethanol diet. C=Control; E=Alcohol.
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Figure 11C. Alcohol-induced hepatic acrolein build-up and consequent ER
stress leads to proapoptotic signaling in mice livers.
Total RNA was evaluated for mRNA expression by real-time PCR using primers
specific for CHOP genes. Data are presented as the mean ± SEM (n=6).
Statistical analysis was performed using Student’s t-test. **p<0.01. C=Control;
E=Alcohol.
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Figure 11D. Alcohol-induced hepatic acrolein build-up and consequent ER
stress leads to proapoptotic signaling in mice livers.
Western blot analysis of CHOP was performed using total cell lysates. Blots were
reprobed with antibody to β-actin to ensure equivalent loading. Densitometry
analysis was performed using Imagelab software. Density ratio was calculated
using β-actin as control. Numbers represent the mean density ratio for each
group of mice pair-fed control or ethanol diet. C=Control; E=Alcohol.
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Hepatic acrolein accumulation and ER stress are accompanied by
steatosis, hepatocyte apoptosis and liver injury
Previous studies have shown that hepatic ER stress is causally linked to steatosis
[76]. We examined fat accumulation in the liver. Consistent with hepatic acrolein
and ER stress, we observed substantial microvesicular and macrovesicular
hepatic steatosis in alcohol-exposed mice compared to controls, as seen by lipid
droplet accumulation by Hematoxylin and Eosin (H&E) and Oil Red O staining
(Figure 12A). Further, the activation of proapoptotic signaling culminated in
apoptotic cell death in the livers of alcohol-fed mice, as seen by a significant
increase in TUNEL (Terminal deoxynucleotidyl transferase dUTP nick-end labeling
assay) positive staining in the livers of alcohol-fed mice compared to control
(Figure 12A), which led to greater liver injury as shown by elevated serum ALT
(Alanine aminotransferase) and AST (Aspartate aminotransferase) (Figure 12B).
Thus, concomitant with alcohol-induced accumulation of acrolein and ER stress,
an increase was observed in hepatic steatosis and hepatocyte apoptosis, leading
to liver injury in alcohol-fed mice.
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Figure 12A. Alcohol-induced acrolein and ER stress leads to steatosis,
hepatocyte apoptosis and liver injury in mice livers.
Hepatic steatosis [by H&E (40x magnification) and Oil Red O staining (20x
magnification)], and apoptosis [by TUNEL staining (20x magnification)].
C=Control; E=Alcohol.
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Figure 12B. Alcohol-induced acrolein and ER stress leads to steatosis,
hepatocyte apoptosis and liver injury in mice livers.
Liver injury – serum ALT and AST. Mean ± SEM, n=6 mice. **p<0.01 and
***p<0.001 compared to control by Student’s t-test. C=Control; E=Alcohol.
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Acrolein mimics the in vivo effects of alcohol in cultured hepatic cells
Along with acrolein, alcohol metabolism in the liver is capable of giving rise to many
toxic metabolites including HNE and malondialdehyde. Hence, to isolate and
determine the sole contribution of acrolein in alcohol-induced hepatic injury, we
used H4IIEC cells to examine the direct in vitro effects of acrolein in comparison
to alcohol, particularly pertaining to induction of ER stress and hepatocyte cell
death. Similar to alcohol exposure, direct acrolein exposure of H4IIEC cells
resulted in considerable acrolein adduct accumulation (Figure 13A).

Further,

analogous to alcohol exposure, direct in vitro acrolein exposure of hepatocytes
resulted in ER stress and cell death. We exposed H4IIEC cells to variable
concentrations of either alcohol (50mM, 100mM or 200mM) or acrolein (20µM or
30µM) for either 6h (for mRNA) or 24h (for protein). These concentrations of
alcohol represent levels that may be encountered with moderate to high alcohol
consumption in humans. The exact levels of acrolein that may be generated in the
liver following alcohol consumption are difficult to predict, and the acrolein
concentrations used here are based on published studies [77] and represent
pathophysiological levels that caused hepatocyte apoptosis. Exposure of H4IIEC
cells to either acrolein or alcohol yielded similar results; both triggered ER stress
and increased ATF3 and ATF4, with minimal upregulation of GRP78 and GRP94,
but a robust increase in proapoptotic CHOP (Figure 13B – mRNA and Figure 13C
– protein). Further, consistent with the induction of CHOP, we observed a
corresponding loss of cell survival (Figure 13D). Thus, our data demonstrate that
acrolein duplicates the effects of alcohol in cultured hepatic cells, indicating that
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the adverse effects of alcohol may be attributed to elevated acrolein in the liver
occurring as a result of alcohol consumption.
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Figure 13A. Acrolein mimics the in vivo effects of alcohol and causes ER
stress and cell death in cultured hepatic cells.
Accumulation and quantification of acrolein adducts (immunocytochemistry using
specific FDP-lysine antibodies - 20x magnification) in H4IIEC cells treated for
24h. **p<0.01 and ***p<0.001 compared to control by ANOVA - Bonferroni
analysis. C = control; E = 200mM alcohol; and A = 30µM acrolein.
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Figure 13B. Acrolein mimics the in vivo effects of alcohol and causes ER
stress and cell death in cultured hepatic cells.
Total RNA was evaluated for mRNA expression ATF3, ATF4, GRP78, GRP94
and CHOP by real-time PCR at 6h
C=Control; E=alcohol (200 mM); A=Acrolein (30 µM). Mean ± SEM, n=3
experiments. *p<0.05 and **p<0.01 compared to control by ANOVA - Bonferroni
analysis.
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Figure 13C. ER stress gene expression ATF3, ATF4, GADD/CHOP, GRP78,
and GRP94 by alcohol (E) or acrolein (A).
H4IIEC cells were treated with varying concentrations of ethanol (50mM, 100mM,
and 200mM) and acrolein (20μM and 30μM) for 24 hours. Western blot analysis
was performed using total cell lysates. Blots were probed with ATF3, ATF4,
GADD/CHOP, GRP78, and GRP94 antibodies, then stripped and reprobed with
antibody to β-actin to ensure equivalent loading. Densitometry analysis was
performed using Imagelab software. Density ratio was calculated using β-actin as
control. Numbers represent mean density ratio for each treatment.
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Figure 13D. Cell viability of cultured hepatocytes from alcohol (E) or
acrolein (A) toxicity.
Cell viability was measured by MTT assay as described in methods. E=Alcohol
200mM and A= acrolein 30μM. Data are presented as the mean ± SEM.
Statistical analysis was performed using GraphPad Prism Software using oneway ANOVA followed by Bonferroni posttest. *p<0.05 compared to Control (n=3).
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Acrolein scavengers exhibited protective effects both in vitro and in vivo
In order to confirm the contribution of acrolein and establish its pathogenic role in
alcohol-induced ER stress and liver injury, we tested known acrolein scavengers
to mitigate the injurious effects of acrolein build-up. In this study, we used an
acrolein scavenger, hydralazine, which is known to neutralize free acrolein [78, 79]
and acrolein-protein adducts [47, 80], both of which are cytotoxic. Also, hydralazine
was shown to effectively prevent acrolein-mediated cell death and tissue damage
in spinal cord injury [46, 81]. Additionally, we also used carnosine (beta-alanyl
histidine, an endogenous dipeptide) that is known to scavenge aldehydes such as
acrolein, and to have beneficial effects against acetaminophen-induced liver injury
[82]. H4IIEC cells were pretreated with hydralazine or carnosine for 1h prior to
alcohol or acrolein exposure, and the effect on cell viability was monitored by the
MTT assay. Acrolein- or alcohol-induced cell death was significantly attenuated by
both acrolein scavengers, and hydralazine was slightly more effective (Figure 14A).
Finally, to firmly establish the role of acrolein in the development of ALD in
vivo, we also tested the efficacy of hydralazine in scavenging acrolein and
protecting against alcohol-induced liver injury in the NIAAA murine model of ALD.
Hydralazine (5mg/kg body weight, dose based on previous literature [79, 81]) was
administered by daily intraperitoneal injection during the 10-day alcohol feeding
regimen. As noted previously, consumption of the alcohol diet resulted in
significant hepatic acrolein adduct accumulation and steatosis in the liver, and the
acrolein scavenger hydralazine effectively blocked alcohol-induced acrolein
formation and adduct accumulation (Figure 14B) and dramatically reduced hepatic

69

steatosis as seen by histological examination and confirmed by Oil Red O staining
(Figure 14B). Further, alcohol-induced hepatic ER stress and transcriptional
upregulation of hallmark ER stress mRNAs (ATF3, ATF4, CHOP and GRP78)
were also substantially attenuated by hydralazine, most to near control levels
(Figure 14C). Importantly, hydralazine prevented alcohol-induced proapoptotic
signaling and activation of JNK, procaspase12 and CHOP (Figure 14D). A
corresponding decrease was seen in alcohol-induced hepatic apoptosis as seen
by decreased TUNEL positive cells (Figure 14E). Lastly, hydralazine showed
marked protective effects against alcohol-induced liver injury with significantly
reduced serum ALT and AST levels (Figure 14F). These data demonstrate that
targeting and sequestration/neutralization of alcohol-induced hepatic acrolein
accumulation by hydralazine administration significantly attenuated ER stress,
apoptosis and liver injury, and protected against ALD in mice (Schematic - Figure
25).

70

Figure 14A. Acrolein scavengers exhibit protective effects in vitro.
Cell survival in H4IIEC cells by MTT assay (24h). Mean ± SEM, n=3 experiments.
*p<0.05 compared to the corresponding treatment of E or A by ANOVA Bonferroni analysis. C = control; E = 200mM alcohol; and A = 30µM acrolein;
CAR=Carnosine; Hyd=Hydralazine.
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Figure 14B. Acrolein scavengers exhibit protective effects in mice livers.
Hepatic acrolein adduct accumulation in mice (20x magnification), and hepatic
steatosis by H&E (80x magnification) and Oil Red O staining (20x magnification).
C=Control; E=Alcohol; Hyd+E=Hydralazine+Alcohol.
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Figure 14C. Acrolein scavengers exhibit protective effects in mice livers.
ATF3, ATF4, GRP78, GRP94 and CHOP mRNA levels. Data are presented as
mean ± SEM (n=6 mice). *p<0.05 and ***p<0.001 compared to E by ANOVA Bonferroni analysis. C=Control; E=Alcohol; Hyd+E=Hydralazine+Alcohol.
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Figure 14D. Acrolein scavengers exhibit protective effects in mice livers.
Protein levels of phospho-JNK and total JNK, pro- and cleaved/active caspase
12, and CHOP. Numbers represent mean densitometry ratios normalized to
corresponding control proteins (total JNK or β-actin). C=Control; E=Alcohol;
Hyd+E=Hydralazine+Alcohol.

74

Figure 14E. Acrolein scavengers exhibit protective effects in mice livers.
Apoptosis by TUNEL staining (80x magnification), with quantification of
apoptosis. **p<0.01 compared to E by ANOVA - Bonferroni analysis. C=Control;
E=Alcohol; Hyd+E=Hydralazine+Alcohol.
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Figure 14F. Acrolein scavengers exhibit protective effects in mice livers.
Liver injury – serum ALT and AST. Mean ± SEM, n=6 mice. **p<0.01 and
***p<0.001 by ANOVA - Bonferroni analysis. C=Control; E=Alcohol;
Hyd+E=Hydralazine+Alcohol.
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RESULTS SECTION II.
Increasing evidence suggests that interactions between the intestine and liver (gutliver axis) play a critical role in the development/progression of ALD [49].
In the Results Section I above, we discussed the contributory role of acrolein to
the hepatic aspect of alcohol-induced liver injury. This section describes the
intestinal effects of acrolein in ALD using cultured human intestinal epithelial cells
(Caco-2), and the chronic+binge murine model of ALD.
Alcohol consumption leads to intestinal acrolein generation, accumulation
of acrolein adducts and serum endotoxemia
Alcohol consumption causes lipid peroxidation and leads to acrolein adducts
accumulation. In order to validate our hypothesis that acrolein disrupts the
intestinal epithelial barrier leading to increased gut permeability, we first examined
whether alcohol consumption in mice led to acrolein buildup in the intestine. The
ileum was investigated since it is critical for nutrient absorption, and it has been
demonstrated to be affected under pathological disease conditions, such as
ulcerative colitis and alcoholic liver disease [83]. From our data, a marked increase
was observed in the levels of acrolein-protein adducts (brown staining of acroleinFDP-lysine adducts) in the ileum of alcohol-fed mice (Figure 15) compared to
controls,

showing

that

alcohol

generation/accumulation of acrolein.

consumption

led

to

the

intestinal

The alcohol-induced acrolein adduct

accumulation was largely in the epithelium, lacteal, and lamina propria.
Hydralazine, an acrolein scavenger, which effectively trapped acrolein-protein
adducts, lowered acrolein adduct accumulation in the ileum. These data show that
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hydralazine can reduce the accumulation of acrolein protein adducts in the ileum
of alcohol fed animals.
In order to test if the clearance of acrolein-protein adducts by hydralazine
improves intestinal barrier function, we examined the level of endotoxin in the
serum of the mice. An elevated LPS level was detected in the alcohol-fed mice
compared to control (Figure 16) which indicated disruption of intestinal barrier
function. In our previous liver data, hydralazine, the acrolein scavenger, showed a
protective effect against alcohol-induced ER stress and liver injury. Interestingly,
the increased LPS level was significantly attenuated by hydralazine in the serum
compared to the alcohol group. These data demonstrate that alcohol causes
intestinal barrier dysfunction and leads to increased gut permeability which, in turn,
allows elevated LPS levels in the serum. Hydralazine, which is known to neutralize
free acrolein [78, 79] and acrolein-protein adducts [47, 80], exhibits a protective
effect in alcohol induced endotoxemia. Thus, hydralazine, the acrolein scavenger,
attenuated alcohol induced endotoxemia.
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Figure 15: Exposure to alcohol causes acrolein adduct buildup in the ileum
of mice.
Accumulation of acrolein adducts in mice ileum by immunohistochemistry using
specific FDP-lysine antibodies (20x).
C=Control; E=Ethanol; HYD+E=Hydralazine+ethanol.
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Figure 16: Hydralazine attenuated alcohol-induced serum endotoxemia.
Serum LPS levels. Data are presented as mean ± SEM (n=6 mice). *p<0.05
compared to E by ANOVA - Bonferroni analysis. C=Control; E=Ethanol;
HYD+E=Hydralazine+ethanol. (n=6).
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Caco-2 cells were used to study the involvement of acrolein in the intestine
in ALD.
From our animal data, we saw accumulation of acrolein protein adducts in the
ileum and a corresponding rise of serum endotoxemia was observed in the alcoholfed mice. In order to mimic the in vivo acrolein effect on the intestine, the direct
effects of acrolein were investigated using a well characterized and accepted
model of the intestine: murine cultured intestinal epithelial Caco-2 cells, which form
a polarized confluent monolayer that mimics the intestinal epithelium [66]. Cells
were grown for 21 days to form epithelial monolayers and were then treated with
alcohol or acrolein to compare their effects. Acrolein adduct accumulation was
seen in Caco-2 cells that were treated for 24h with alcohol (200mM) or acrolein
(20uM) compared to untreated cells (Figure 17). To determine whether acrolein
adduct accumulation affected the Caco-2 epithelial barrier, we measured intestinal
barrier function and permeability using Trans Epithelial Electrical Resistance
(TEER) and FD-4 leakage, respectively. Alcohol treatment for 6h caused a
significant decrease in the epithelial TEER measurements in a dose-dependent
manner. Consistent with these results, the paracellular permeability to FD-4 was
significantly increased by alcohol exposure in a dose-dependent manner (Figure
18). Similar to alcohol, direct acrolein exposure for 6h also caused a significant
decrease in the epithelial TEER measurements, and a corresponding increase in
paracellular permeability to FD-4 (Figure 19). These data indicated that alcohol or
alcohol induced acrolein protein adducts promote disruption of intestinal barrier
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function and an increase in intestinal barrier permeability with increasing
concentrations of alcohol or acrolein.
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Figure 17: Exposure to alcohol or acrolein leads to acrolein adduct
accumulation in Caco-2 cell monolayers.
Accumulation of acrolein adducts by immunocytochemistry using specific FDPlysine antibodies (20x magnification) in Caco-2 cells treated for 24h as follows:
C=Control; E=Ethanol (200mM); A=Acrolein (20µM).
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Figure 18. Alcohol exposure decreases barrier function and increases
permeability (FD-4) (TEER) Caco-2 cells.
C=Control; E=Ethanol (%) Data are presented as the mean ± SEM. Statistical
analysis was performed using GraphPad Prism Software using one-way ANOVA
followed by Bonferroni posttest.*p<0.05 and **p<0.01 compared to Control (n=3).
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Figure 19. Acrolein exposure decreases and increases permeability (FD-4)
barrier function (TEER) in Caco-2 cells.
C=Control; A=Acrolein (µM). Data are presented as the mean ± SEM. Statistical
analysis was performed using GraphPad Prism Software using one-way ANOVA
followed by Bonferroni posttest. *p<0.05, **p<0.01 and ***p<0.001 compared to
Control (n=3).
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Alcohol or acrolein exposure leads to down regulation and redistribution of
TJPs
Tight junction proteins (TJP; e.g., ZO-1, claudin-1 and occludin) are critical
components of the intestinal barrier. ZO-1 is the tight junction scaffolding protein
and it has been reported that reduced level of ZO-1 leads to disruption of the
intestinal mucosa and an increase in permeability after intestinal ischemiareperfusion injury [84]. Claudin-1 plays an important role in the maintenance of gut
integrity. Decreased claudin-1 leads to increased intestinal permeability while
overexpressed claudin-1 reduces paracellular permeability and maintains the
integrity of intestinal barrier [85]. We demonstrated that alcohol exposure
downregulated TJP mRNAs (ZO-1, occludin and claudin-1) from 3% to 5% (Figure
20) in 24 hours. Similar to alcohol treatment, the treatment of acrolein at 10 to 20
uM also showed downregulation of TJP mRNAs (ZO-1, occludin and claudin-1)
(Figure 19) in 24 hours. The effect of acrolein (10 and 20 uM) on the protein levels
of TJPs (ZO-1, occludin, claudin-1) was also evaluated (Figure 21).

The effects

on total protein levels were variable; claudin-1 and occludin were downregulated
by acrolein, in agreement with the decrease in mRNA levels, but ZO-1 was
increased slightly (Figure 21). Since the location and membrane association of the
TJPs is critical for their function, any alterations in their localization can greatly
impact the regulation of barrier permeability. Hence, we examined the protein
levels in the membrane-bound (insoluble in detergent) and the soluble, or nonmembrane associated, fractions (Figure 22). Acrolein treatment resulted in a
dramatic increase in the soluble protein levels of all three TJPs, indicating that their
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membrane association was significantly disrupted. We observed a corresponding
decrease in the insoluble levels of both ZO-1 and claudin, but not occludin (Figure
22).
To further support these findings and to examine TJP redistribution in whole
cells rather than extracted protein samples, we used immunofluorescence
microscopy to assess the localization of ZO-1 (as a representative TJP) upon
exposure to alcohol or acrolein. Both alcohol (2% or 5%) and acrolein (10 and 20
µM) showed significant and similar dose-related effects on the distribution pattern
of ZO-1 (Figure 23). Compared with the untreated control cells which exhibited a
smooth regular pattern of ZO-1 staining at the cell borders between the adjacent
epithelial cells, cells treated with either acrolein or alcohol displayed an uneven
(ruffled) distribution. ZO-1 was decreased and discontinuous at some locations,
while a random accumulation and clumping of ZO-1 was seen in other cells.
Overall, our data showed that alcohol or acrolein exposure caused the
downregulation and/or redistribution of TJPs, leading to consequent intestinal
barrier dysfunction and increased permeability.
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Figure 20. In vitro alcohol exposure down-regulates TJP mRNAs. (Real time
qPCR).
Total RNA was evaluated for mRNA expression ZO-1, Occludin, and Claudin in
Caco-2 cells treated for 24h.
C=Control; E=Alcohol. Mean ± SEM, n=3 experiments. *p<0.05 and
**p<0.01compared to control by ANOVA - Bonferroni analysis.
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Figure 21. In vitro acrolein exposure down-regulates TJP mRNAs. (Real
time qPCR).
Total RNA was evaluated for mRNA expression ZO-1, Occludin, and Claudin in
Caco-2 cells treated for 24h.
C=Control; A=Acrolein. Mean ± SEM, n=3 experiments. *p<0.05, **p<0.01, and
***p<0.001 compared to control by ANOVA - Bonferroni analysis.
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Figure 22. Acrolein exposure alters protein levels of TJP.
Western blot analysis of ZO-1, Occludin, and Claudin were performed using tight
junction total, soluble, and insoluble protein lysates. Blots were reprobed with
antibody to β-actin to ensure equivalent loading. Densitometry analysis was
performed using Imagelab software. Density ratio was calculated using β-actin as
control. Numbers represent the average density ratio for each treatment.
C=Control; A=Acrolein (uM).
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Figure 23. Alcohol treatment causes disrupted distribution of ZO-1 protein
in Caco-2.
Caco2 cells were treated with or without alcohol for 24 hours, and ZO-1 protein
localization was assessed by immunofluorescent microscopy. Results are
representative of 3 experiments. (magnification, 40X). C=Control; E=Alcohol (%).
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Figure 24. Acrolein treatment causes disrupted distribution of ZO-1 protein
in Caco-2.
Caco2 cells were treated with or without acrolein for 24 hours, and ZO-1 proteins
localization was assessed by immunofluorescent microscopy. Results are
representative of 3 experiments. (magnification, 40X). C=Control; A=Acrolein
(µM).
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CHAPTER 4
DISCUSSION
Alcohol consumption is a major health problem worldwide and in the USA;
it has no FDA-approved therapy for any stage of ALD. Therefore, it is critical to
investigate the mechanisms involved in ALD, and to identify novel therapeutic
targets and strategies for the prevention and treatment of ALD. In this study, we
pursued in vitro and in vivo studies to demonstrate the role of the lipid peroxidation
byproduct, acrolein, in contributing to alcohol-induced gut barrier dysfunction and
hepatic ER stress, steatosis, cell death and liver injury in the pathogenesis of gutliver injury of ALD. Our study demonstrates that: (i) alcohol consumption generates
hepatic acrolein, triggers pathological ER stress and hepatocyte apoptosis, with
insufficient activation of ER-adaptive/protective responses; (ii) alcohol-induced
acrolein is a major mediator of hepatic ER stress, cell death and injury, and is a
potential therapeutic target in ALD; (iii) removal/clearance of acrolein by
scavengers has therapeutic potential in ALD; and (iv) alcohol consumption
generates intestinal acrolein, down-regulates tight junction proteins, alters their
localization, and disrupts intestinal barrier function (Figure 25). Acrolein is formed
both endogenously from lipid peroxidation and exogenously from environmental
and dietary exposures such as air pollution, cigarette smoking, automobile
exhausts, charred meat, and fried foods. The accumulation of acrolein can occur
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and cause problems in other diseases that involve increased lipid peroxidation and
oxidative stress.
Our hepatic results demonstrated significant generation/accumulation of
acrolein in the liver following alcohol exposure resulting in cytoplasmic and nuclear
accumulation of acrolein adducted proteins. The accumulation of acrolein-protein
adducts triggered subsequent hepatic ER stress leading to hepatocyte cell death
and liver injury. Notably, all three ER stress pathways involving the ER sensors
PERK, IRE1 and ATF6, were activated; however, not all ER stress genes were
affected in the same way. Alcohol consumption appeared to trigger ER stress and
induce apoptotic signaling (JNK, Caspase12 and CHOP), while simultaneously
suppressing UPR-protective responses (XBP1 splicing and ER chaperones
(GRP78 and 94)). The differential regulation of ER stress genes may be via altered
signal transduction, or by direct or indirect protein adduction. Also, the nuclear
accumulation of acrolein adducts may indicate adduction and alteration of function
of transcription factors or chromatin-modifying proteins such as histone
deacetylases and DNA/histone methylases, which likely have significant effects on
downstream gene expression. The exact mechanisms by which acrolein adduct
accumulation causes ER stress, and the identity and functionality of the proteins
adducted by acrolein are currently under investigation.
Oxidative stress is known to induce ER stress, however, the mediators
responsible for such effects have not been clearly identified. Alcohol-induced
oxidative stress and aldehyde generation is shown to occur in the absence of ER
stress in a model of early ALD, suggesting that ER stress may be a downstream
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consequence of oxidant burden [86]. Our data clearly demonstrate a direct
mechanistic link and identify acrolein as a major pathogenic initiator of alcoholinduced hepatic injury. A causal role of acrolein in the pathogenesis of ALD is
further supported by the observation that clearance of this toxic molecule by
hydralazine (a known acrolein scavenger) largely prevented alcohol-induced
acrolein buildup, ER stress, cell death and injury. With regard to acrolein
accumulation during the development of ALD, our novel results show that alcoholmediated downregulation of GSTP may be a key mechanism that reduces the
normal metabolism/clearance of acrolein, thereby contributing to hepatic
accumulation of acrolein and consequent liver injury. Indeed, GSTP may be a
potential therapeutic target, and pharmacological activation of GSTP may be of
benefit to attenuate of ALD. Additionally, our data indicate that alcohol metabolism
is essential, and that both ADH- and CYP2E1-dependent pathways contribute to
acrolein accumulation. Importantly, our data show that acetaldehyde, the first
metabolite of alcohol, plays a key role in alcohol-induced acrolein formation since
direct exposure to acetaldehyde resulted in substantial acrolein accumulation in
H4IIEC cells. Moreover, acetaldehyde may further support acrolein formation via
upregulation of spermine oxidase which catalyzes the formation of free acrolein by
oxidation of spermine as reported by Uemura et al. [87]. The vital role of ALDH2 in
detoxification of aldehydes (both acetaldehyde and acrolein) was clearly shown by
the observation that Alda1 (ALDH2 agonist) prevented alcohol-induced acrolein
accumulation in cultured hepatocytes; these data are in keeping with the recent
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demonstration that Alda1 protects against alcohol-induced steatosis and cell death
[88].
To the best of our knowledge our data demonstrate, for the first time, that
alcohol consumption causes pathological ER stress without sufficient induction of
the adaptive/protective responses involving XBP1 splicing and upregulation of ER
chaperones. Thus, insufficient adaptation to ER stress along with proapoptotic
signaling may significantly contribute to hepatic injury in this model of alcohol
consumption. Although XBP1 splicing occurred in a few alcohol-fed mice, GRP78
or GRP94 were not significantly upregulated, suggesting that additional factors
(such as other proteins or epigenetic modifications) may also be involved. A similar
discordant lack of correlation has been reported in dermal fibroblasts between
chaperone gene expression and upstream signal transduction (cleavage of ATF6
and splicing of XBP1) [89]. Our data in the chronic binge murine model showing
minimal to no increase in chaperones GRP78 and GRP94 differs from the murine
intragastric alcohol feeding model, which showed substantial upregulation of
GRP78, along with CHOP and hepatic steatosis and injury [37]. Also, in guineapigs fed alcohol, liver steatosis and apoptosis were accompanied by increased
mRNA and protein levels of CYP2E1 and GRP78, and activated caspase-12 [38].
These variations in ER stress-associated gene expression may reflect differences
in model systems pertaining to animals, routes of alcohol feeding or temporal
patterns of gene expression. Our study emphasizes the important role of
pathological ER stress in alcohol-induced liver injury in this model of ALD, and
indicates that impaired ER adaptive responses (e.g., GRP78) may contribute

96

significantly to injury in ALD, as has been described in other forms of liver injury
[90]. ER stress is known to result in JNK activation through the IRE1-TRAF
pathway; however, several other stimuli also activate JNK, including TNF and
TRAIL, which are known to be elevated in alcohol-fed mice. The direct causative
role of ER stress in JNK activation and alcohol-induced injury is clearly suggested
but not established by our work; future studies to confirm this concept will involve
investigating the effects of pharmacological or genetic inhibition of ER stress on
JNK activation, apoptosis and liver injury.
Notably, in addition to showing the pathogenic contribution of acrolein in the
development of experimental ALD, our study provides novel and exciting evidence
that acrolein removal through scavenging by hydralazine is an effective way to
mitigate alcohol-induced hepatic ER stress, steatosis and injury in experimental
ALD, both in vitro and in vivo. Although the protective effects of hydralazine are
primarily reported against acrolein [47], it is possible that hydralazine may also
interact with and neutralize other toxic aldehydes such as HNE, thereby providing
added protection in ALD. In our study, hydralazine prevented liver injury when
administered from the start of alcohol feeding; additional studies are needed to test
its efficacy in a treatment paradigm. Although, the data convincingly demonstrate
that acrolein removal/clearance by hydralazine may be a novel and effective
treatment modality, the use of hydralazine in the treatment of ALD patients may be
somewhat limited since hydralazine has vasodilator properties. Alternative
compounds, with the same hydrazine-based acrolein scavenging mechanism but
without the vasodilator effects, such as dihydralazine and the antidepressant
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phenelzine [91], may need to be investigated for safety and efficacy in ALD.
Further studies are needed to understand the exact mechanism by which alcoholinduced acrolein leads to ER stress, and to examine the contribution of acrolein in
alcohol-induced hepatic inflammation.
In addition to hepatic effects, alcohol-induced increased intestinal
permeability and consequent systemic endotoxemia are known to be important in
the pathogenesis of ALD. Alcohol is associated with intestinal barrier dysfunction
and increased intestinal permeability (‘’leaky gut’’) which results in translocation of
bacteria and increased systemic endotoxemia. Therefore, it becomes important to
determine the role of acrolein in intestinal barrier dysfunction and the mechanism(s)
by which it occurs in order to assess potential therapeutic targets for prevention
and/or treatment of ALD. Our results show that acrolein adducts accumulate in the
lamina propria and in the border of epithelial cells in the villi of the ileum in alcohol
treated mice. Similar to hepatic data where the acrolein scavenger, hydralazine,
effectively protected against alcohol-induced hepatic ER stress, steatosis and
injury in experimental ALD, our intestinal data also show that hydralazine
significantly reduced acrolein adduct formation in the ileum and alleviated ‘‘leaky
gut’’ as indicated by the decrease in serum endotoxin.
These observations led us to conduct a further examination of the molecular
mechanisms underlying acrolein-mediated intestinal barrier dysfunction and
intestinal permeability. A well-established in vitro model of intestinal barrier
function and intestinal permeability (Caco-2 cell monolayers grown on permeable
inserts) were used for this study. Direct in vitro exposure of Caco-2 cells to alcohol
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resulted in acrolein adduct accumulation. Alcohol consumption is known to result
in the generation of acetaldehyde in the intestine; however, it remains unclear as
to whether alcohol is metabolized by gut microbiota or by intestinal epithelial (and
other) cells, or both. Our data clearly indicate that alcohol is metabolized by the
epithelial cells giving rise to acrolein. Also, our data indicate that alcohol-induced
acrolein adduct accumulation in the intestinal epithelial cells is a driving force to
cause barrier dysfunction and leaky gut. Our in vitro data indicate that acrolein
mimics the effect of alcohol in the epithelial cells and alters the localization and
redistribution of tight junction proteins, hence causes the disruption of intestinal
barrier function and enhances intestinal permeability. The similarity of the results
observed with acrolein compared to alcohol provide further confirmation that
alcohol-induced acrolein disrupts intestinal barrier function and leads to the
increased intestinal permeability and further contributes to the pathogenesis of
ALD.
In conclusion, acrolein is the most reactive and toxic aldehyde generated
through lipid peroxidation. Accumulation of acrolein adducts was seen in response
to alcohol consumption in mouse livers and intestines. Acrolein adduct
accumulation correlated with disruption of TJPs, intestinal barrier dysfunction, and
intestinal permeability in the gut. Moreover, accumulation of acrolein adducts is
associated with hepatic steatosis, JNK activation, ER stress, apoptosis and liver
injury, which are recognized etiologic factors in gut-liver injury of ALD. We used
cultured hepatic and intestinal cells to examine the in vitro effects of acrolein
compared to alcohol. Alcohol-induced in vivo intestinal effects were mimicked by
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acrolein in vitro Caco-2 cells, with downregulation of tight junction proteins,
disruption of TEER, and increased FD-4 permeability. Similar to alcohol, in vitro
acrolein triggered hepatocyte ER stress and induced apoptosis. Together the data
indicate that acrolein may mediate the adverse intestinal and hepatic effects of
alcohol. Notably, these effects were attenuated by the acrolein scavenger,
hydralazine, suggesting its therapeutic potential in the gut-liver injury of ALD.
Limitation of the study: The concentration of free acrolein is difficult to
measure in biological samples due to its high reactivity and lability. In this study,
we used an indirect measure of acrolein and only assessed the levels of FDPlysine acrolein adducts, and no other adducts that may be formed with cysteines
and histidines. The development of more efficient novel assays for free acrolein
and adducts would facilitate more accurate measurement of acrolein in ALD. In
the intestinal barrier function study, we focused on the TJPs. However, the
mucus layer (mucins and intestinal trefoil factors) [90] and/or antimicrobial
peptides also critically contribute to gut integrity and are affected by alcohol.
These will be highly relevant studies as a future direction for the project.
Currently, there are several models of ALD that are similar in many
aspects, but also differ somewhat. Moreover, no animal model perfectly
simulates human ALD. Our data are limited to one single model of chronic binge.
To emphasize the relevance of our findings, the reproducibility across animal
models would need to be further examined. Moreover, mouse data may not
exactly correlate to the responses in human ALD; hence, the role of acrolein in
human ALD would need to be investigated and established.
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Clinical relevance: About 30% of heavy alcohol drinkers develop severe
ALD, and dietary and environmental factors are thought to be critical determinants.
Acrolein is a common environmental and dietary pollutant and our study shows
that it is a major mediator of the adverse effects of alcohol and plays a causal role
in ALD pathogenesis. Our group has shown that diets enriched in linoleic acid
(common dietary PUFA) exacerbate alcohol-induced liver injury [83], and
consumption of linoleic acid has increased more than 3-fold over the last century,
thereby increasing the substrate availability for LPO and subsequent acrolein
generation. Additionally, acrolein is a major aldehyde component of cigarette
smoke [92]; cigarette smoking is common in persons consuming alcohol and is
known to negatively impact alcoholic liver disease. Thus, environmental and
dietary acrolein exposures may add to endogenously generated acrolein with
significant and clinically relevant pathogenic consequences. Our results indicate
that acrolein is a major pathogenic contributor and may be an important therapeutic
target in ALD. Notably, our study demonstrates for the first time that acrolein
neutralization/clearance may be an effective strategy for curtailing alcohol-induced
acrolein-mediated gut-liver injury in the development of ALD. Hence, acrolein
scavengers such as hydralazine may represent a novel therapeutic approach for
the prevention/treatment of ALD.
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Figure 25. Schematic: Acrolein mediates alcohol-induced intestinal barrier
dysfunction, permeability and hepatic ER stress, apoptosis and injury in
ALD, and the scavenger, hydralazine, prevents these effects.
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